Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_assertion description "[Despite the evidence of early insulin treatment lowering macrovascular (coronary artery disease, peripheral arterial disease and stroke) and microvascular (diabetic nephropathy, neuropathy and retinopathy) complications of T2DM, controversy exists among physicians on how to initiate and intensify insulin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_assertion evidence source_evidence_literature NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_assertion SIO_000772 23584214 NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_assertion wasDerivedFrom befree-20140225 NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_assertion wasGeneratedBy ECO_0000203 NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP567803.RA-QCem3jCV3Hu9Asl4E1VVpVHAmbLqW7__3Q-QFknIs0130_provenance.